Use of insulin in diabetes: a century of treatment
- PMID: 26554270
- DOI: 10.12809/hkmj154557
Use of insulin in diabetes: a century of treatment
Abstract
Insulin is a key player in the control of hyperglycaemia for patients with type 1 diabetes mellitus and selected patients with type 2 diabetes mellitus. There have been many advances in insulin drug delivery from its first administration as a crude pancreatic extract till today. The traditional and most predictable method for administration of insulin is by subcutaneous injection. Currently available insulin delivery systems include insulin syringes, infusion pumps, jet injectors, and pens. The major drawback of insulin therapy is its invasive nature. Non-invasive delivery of insulin has long been a major goal for the treatment of diabetes mellitus. Although there have been improvements in insulin therapy since it was first conceived, it is still far from mimicking the physiological secretion of pancreatic β-cells, and research to find new insulin formulations and new routes of administration continues. This article reviews the emerging technologies, including insulin inhalers, insulin buccal spray, insulin pill, islet cell transplant, and stem cell therapy, as treatment options for diabetes mellitus.
Keywords: Diabetes mellitus, type 2; Insulin/administration & dosage.
Similar articles
-
Endless Pursuit: Evolution of Insulin Administration.Curr Pharm Biotechnol. 2018;19(9):742-753. doi: 10.2174/1389201019666180918112922. Curr Pharm Biotechnol. 2018. PMID: 30227816 Review.
-
Recent approaches in insulin delivery.Drug Dev Ind Pharm. 1998 Jul;24(7):589-97. doi: 10.3109/03639049809082359. Drug Dev Ind Pharm. 1998. PMID: 9876502 Review.
-
Alternative routes of insulin delivery.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Oct;34(10):933-48. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19893243 Review.
-
Pharmacokinetic considerations of new insulin formulations and routes of administration.Clin Pharmacokinet. 1997 Oct;33(4):285-301. doi: 10.2165/00003088-199733040-00004. Clin Pharmacokinet. 1997. PMID: 9342504 Review.
-
Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.Pediatr Endocrinol Rev. 2003 Dec;1(2):94-100. Pediatr Endocrinol Rev. 2003. PMID: 16437014 Review.
Cited by
-
Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches.Biotechnol Lett. 2022 Feb;44(2):203-238. doi: 10.1007/s10529-022-03232-3. Epub 2022 Feb 4. Biotechnol Lett. 2022. PMID: 35119572 Review.
-
Advances in Subcutaneous Delivery Systems of Biomacromolecular Agents for Diabetes Treatment.Int J Nanomedicine. 2021 Feb 17;16:1261-1280. doi: 10.2147/IJN.S283416. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33628020 Free PMC article. Review.
-
Advances in transdermal insulin delivery.Adv Drug Deliv Rev. 2019 Jan 15;139:51-70. doi: 10.1016/j.addr.2018.12.006. Epub 2018 Dec 8. Adv Drug Deliv Rev. 2019. PMID: 30528729 Free PMC article. Review.
-
Light Control of Insulin Release and Blood Glucose Using an Injectable Photoactivated Depot.Mol Pharm. 2016 Nov 7;13(11):3835-3841. doi: 10.1021/acs.molpharmaceut.6b00633. Epub 2016 Oct 15. Mol Pharm. 2016. PMID: 27653828 Free PMC article.
-
An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus.Int J Mol Sci. 2023 May 26;24(11):9328. doi: 10.3390/ijms24119328. Int J Mol Sci. 2023. PMID: 37298274 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical